Trial Profile
A Phase 2, Observer-blind, Randomized, Controlled Study to Evaluate the Safety and Immunogenicity of Two Formulations of Investigational Meningococcal Groups ACYWX Conjugate Vaccine, Administered to Healthy Malian Children 12-16 Months of Age
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Sep 2021
Price :
$35
*
At a glance
- Drugs Pentavalent-meningococcal-conjugate-vaccine-A-C-Y-W-135-X-PATH/Serum-Institute-of-India (Primary) ; Meningococcal vaccine groups A C Y W-135 conjugate
- Indications Meningococcal infections
- Focus Adverse reactions
- Sponsors Serum Institute of India
- 03 Jun 2021 Results published in the New England Journal of Medicine
- 05 Sep 2018 Status changed from active, no longer recruiting to completed.
- 17 Apr 2018 Planned primary completion date changed from 1 May 2018 to 1 Jul 2018.